Group items tagged

Golden chance to learn in-depth about FDA’s regulations and how they are applied to the cosmetics industry. Register for this webinar today.

Webinar on CMO Supplier Quality Agreements and methods to Comply with new FDA and EU Guidelines for Contract Drug Manufacture.

Honokage has been in injection molding packaging area since 1997, and we are the go-to partner for global top brands with our technology and expertise, automated production lines, GMP workshop, strict regulatory to tailor solution and deliver qualified plastic containers for our customers. Choose Us Now.

DCX Systems Limited IPO About Company DCX Systems Limited is among the leading Indian players in the manufacture of electronic sub-systems and cable harnesses. The company commenced operations in 2011 and has been a preferred Indian Offset Partner ("IOP") for foreign original equipment manufacturers ("OEMs") for executing aerospace and defense manufacturing projects. In 2020, the company commissioned a new manufacturing facility at the Hi-Tech Defence and Aerospace Park SEZ in Bengaluru, Karnataka. R&D Capabilities The company has three dedicated R&D facilities, two of which are located at Chennai and Gurgaon and one in Stuttgart, Germany. DCX Systems Limited IPO Details IPO Size INR 500CR IPO Opening Date 31, Oct 2022 IPO Closing Date 2, Nov 2022 Allotment Date 07, Nov 2022 IPO Listing Date 11, Nov 2022 Price Band ₹197 to ₹207per share Minimum 72 Shares Maximum 936 Shares Click on the link to open your Demat account and start trading

DCX Systems Limited IPO Review | Upcoming IPO Details 2022 | Apply or not?

Heranba Industries Ltd IPO is listed last year in the stock market. After the 1 year issue, Heranba Industries ltd has shown significant growth in its sector and the company is almost in Debt free and highest ROE among its competitors, which gives better returns to the investor the company is going to consider a multibagger stock in the future. know the complete analysis of the Heranba Industries.

SQ1 Stem Cell Medical Center is an international research institution in stem cells and modern . biomedicine. We have a GMP-compliant laboratory and more than 30 outstanding experts in various fields of stem cells. Our stem cell therapy is a mature, safe and effective treatment method. We have provided first-class stem cell treatment services to tens of thousands of patients around the world.